about
An ENU mutagenesis screen identifies novel and known genes involved in epigenetic processes in the mouseAntioxidants impair anti-tumoral effects of Vorinostat, but not anti-neoplastic effects of Vorinostat and caspase-8 downregulationWaking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system.Sensitizing basal-like breast cancer to chemotherapy using nanoparticles conjugated with interference peptide.Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells.Functional expression of voltage-gated calcium channels in human melanoma.Nuclear factor-κB2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner.Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway.Expression of somatostatin receptors in human melanoma cell lines: effect of two different somatostatin analogues, octreotide and SOM230, on cell proliferation.Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines.Antioxidants block proteasome inhibitor function in endometrial carcinoma cells.CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells.ATF2 alters melanocyte response and macrophage recruitment in UV-irradiated neonatal mouse skinThe multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms.Crambescidin 800, Isolated from the Marine Sponge Monanchora viridis, Induces Cell Cycle Arrest and Apoptosis in Triple-Negative Breast Cancer Cells.Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activation.Aurantoside C Targets and Induces Apoptosis in Triple Negative Breast Cancer CellsIdentification of novel hypomorphic and null mutations in Klf1 derived from a genetic screen for modifiers of α-globin transgene variegationTumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymersTumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancersPrecision medicine by designer interference peptides: applications in oncology and molecular therapeuticsTriple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptidesSensitizing endometrial cancer to ionizing radiation by multi-tyrosine kinase inhibitionDistinction Between Active and Passive Targeting of Nanoparticles Dictate Their Overall Therapeutic Efficacy
P50
Q33742092-F993F390-3C4F-4976-A0A3-44AFBB4E53F0Q35126359-ABF0EFCE-8685-4552-8AD5-0F7A8D9CEC10Q37645061-1368FFFD-9AFB-4A03-B5BF-834C0B8BE5D1Q38777346-DFF31FB3-610D-4DF0-A843-47B6EB537E1CQ39165456-C9953920-9AE9-4AC3-BCB8-F13A3A5FEADFQ39409759-810F40FD-A38D-4D89-B787-AE6BB3448E9FQ39549560-359828E2-CC05-4D19-B397-6390138F6FF2Q39568919-0E31C074-BB09-4287-ADF9-576B31C254FBQ39741277-6F207E6D-5886-47AE-9EE4-45242CC2090FQ40022877-FDC971AB-A584-4C91-B088-D3C240A72EB6Q40028321-2ECBA5F2-05AB-4910-8E7C-D3EAF8F54CB5Q40056601-CE2086EA-D802-4633-A2E3-12DF85F987E2Q41285700-19032E1B-2FFF-497E-AE92-2E8193DD3710Q43195406-636B4D2F-FF30-4447-96FD-21895E627171Q50117674-7B95DFD6-F4C7-470C-ADD2-10A39F994E3EQ51139885-2758594E-93D9-4153-90DF-EF8793F0B1ACQ57059036-628E9EA3-2FA2-4440-8A19-EC7E5F70CF19Q57186970-E80A7C7E-E38E-4E77-9E70-964371902AE6Q90535138-C8766708-24A7-4C3F-99FC-7695B1AA1847Q90748016-26AD7871-3351-48D0-837E-8B8280E11A13Q90859674-C5524244-06FE-4A52-9CF3-318427C07218Q91760669-63B28148-1905-4B0D-A847-4ECFF6615D6AQ92487520-06F08057-4FC1-4B55-9D4B-12CB8ED404A8Q93153976-4B74A088-405E-4B83-95DC-694D21A09DB0
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Anabel Sorolla
@en
Anabel Sorolla
@nl
type
label
Anabel Sorolla
@en
Anabel Sorolla
@nl
prefLabel
Anabel Sorolla
@en
Anabel Sorolla
@nl
P31
P496
0000-0001-8238-8763